List of FDA reports

Fadini GP, Bonora BM, Avogaro A. SGLT2 inhibitors and diabetic ketoacidosis. Data from the FDA Adverse Event Reporting System. Diabetologia 2017 Detailed characteristics of DKA reports where an SGLT2i was listed among suspect or concomitant drugs in the FAERS from 2014 Q1 to 2016 Q3. “ND” stands for “not determined”, meaning the given FAERS records contain no data on that specific field. The following specifications apply. Primary ID: Unique number for identifying a FAERS report. This is a concatenated key of Case Id and Case version number. Case Id: Number for identifying a FAERS case. Possible duplicate (Yes/No): some FAERS records may be duplicated because more than one SGLT2i may have been associated with the event in a given patient. Outcome: DE, death. LT, life threatening. HO, hospitalization. DS, disability. OT, other serious event.<br>